BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 12383824)

  • 1. Treatment of central retinal vein occlusion by vitrectomy with lysis of vitreopapillary and epipapillary adhesions, subretinal peripapillary tissue plasminogen activator injection, and photocoagulation.
    Lam HD; Blumenkranz MS
    Am J Ophthalmol; 2002 Oct; 134(4):609-11. PubMed ID: 12383824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of central retinal vein occlusion by injection of tissue plasminogen activator into a retinal vein.
    Weiss JN
    Am J Ophthalmol; 1998 Jul; 126(1):142-4. PubMed ID: 9683166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Updated cannulation technique for tissue plasminogen activator injection into peripapillary retinal vein for central retinal vein occlusion.
    van Overdam KA; Missotten T; Spielberg LH
    Acta Ophthalmol; 2015 Dec; 93(8):739-44. PubMed ID: 26310993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arteriovenous adventitial sheathotomy for the treatment of macular edema associated with branch retinal vein occlusion.
    Shah GK; Sharma S; Fineman MS; Federman J; Brown MM; Brown GC
    Am J Ophthalmol; 2000 Jan; 129(1):104-6. PubMed ID: 10653427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Branch retinal vein occlusion. A clinicopathologic case report.
    Bowers DK; Finkelstein D; Wolff SM; Green WR
    Retina; 1987; 7(4):252-9. PubMed ID: 2448855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion.
    Weiss JN; Bynoe LA
    Ophthalmology; 2001 Dec; 108(12):2249-57. PubMed ID: 11733266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of vitrectomy assisted rt-PA injection for the management of branch retinal vein occlusion: case report.
    Christodoulakis EV; Tsilimbaris MK
    Semin Ophthalmol; 2007; 22(2):89-93. PubMed ID: 17564929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal endovascular lysis in ischemic central retinal vein occlusion: one-year results of a pilot study.
    Feltgen N; Junker B; Agostini H; Hansen LL
    Ophthalmology; 2007 Apr; 114(4):716-23. PubMed ID: 17141322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinal surgery for treatment of central retinal vein occlusion.
    Weiss JN
    Ophthalmic Surg Lasers; 2000; 31(2):162-5. PubMed ID: 10743932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term results of endovascular surgery with tissue plasminogen activator injection for central retinal vein occlusion.
    Ishida M; Abe S; Nakagawa T; Hayashi A
    Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2135-2140. PubMed ID: 28803326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radial optic neurotomy as treatment for central retinal vein occlusion.
    Weizer JS; Stinnett SS; Fekrat S
    Am J Ophthalmol; 2003 Nov; 136(5):814-9. PubMed ID: 14597031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-vitrectomy tissue plasminogen activator injection for central retinal vein occlusion.
    Christodoulakis EV; Tsilimbaris MK
    Ophthalmic Surg Lasers Imaging; 2008; 39(3):252-6. PubMed ID: 18556955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal tissue plasminogen activator for the treatment of central retinal vein occlusion.
    Weizer JS; Fekrat S
    Ophthalmic Surg Lasers Imaging; 2003; 34(4):350-2. PubMed ID: 12875471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical macular decompression for macular edema in retinal vein occlusion.
    Mandelcorn MS; Mandelcorn E; Guan K; Adatia FA
    Can J Ophthalmol; 2007 Feb; 42(1):116-22. PubMed ID: 17361252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical treatments of central retinal vein occlusion.
    Parodi MB; Lanzetta P; Guarnaccia G; Friberg T
    Semin Ophthalmol; 2003 Sep; 18(3):142-6. PubMed ID: 15513475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macular hole formation and spontaneous closure after vitrectomy for central retinal vein occlusion.
    Shukla D; Rajendran A; Kim R
    Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1350-2. PubMed ID: 16525823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of surgical treatments for central retinal vein occlusion; RON vs. cannulation of tissue plasminogen activator into the retinal vein.
    Yamamoto T; Kamei M; Sakaguchi H; Oshima Y; Ikuno Y; Gomi F; Ohji M; Tano Y
    Retina; 2009 Sep; 29(8):1167-74. PubMed ID: 19734765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal tissue plasminogen activator for acute central retinal vein occlusion.
    Lahey JM; Fong DS; Kearney J
    Ophthalmic Surg Lasers; 1999 Jun; 30(6):427-34. PubMed ID: 10392729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgical approach to retinal vein occlusion].
    Mester U
    Klin Monbl Augenheilkd; 2005 Apr; 222(4):299-308; quiz R19-R38. PubMed ID: 15844038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intentional complete interruption of a retinal vein after vitrectomy might improve the rate of successful chorioretinal venous anastomosis formation in central retinal vein occlusion.
    Koizumi K; Nishiura M; Yamamoto T; Machida T; Nakamura T; Ouchi M; Kinoshita S
    Graefes Arch Clin Exp Ophthalmol; 2002 Oct; 240(10):787-94. PubMed ID: 12397425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.